Epstein-Barr Virus and the Pathogenesis of T and NK Lymphoma: a Mystery Unsolved

Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy

(2012) Z.-Y. Wang et al.   BLOOD

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

(2012) L. Agnelli et al.   BLOOD

Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type

(2012) Y. Ito et al.   CLINICAL CANCER RESEARCH

Expression of Epstein-Barr Virus-Encoded Proteins in Extranodal NK/T-cell Lymphoma, Nasal Type (ENKL): Differences in Biologic and Clinical Behaviors of LMP1-Positive and -Negative ENKL

(2012) N. Kanemitsu et al.   CLINICAL CANCER RESEARCH

EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency

(2012) Kasandra J Riley et al.   EMBO JOURNAL

The pathological roles of BART miRNAs in nasopharyngeal carcinoma

(2012) Angela K-F Lo et al.   JOURNAL OF PATHOLOGY

Loss of Epstein-Barr Virus–Encoded RNA Expression in Cutaneous Dissemination of Natural Killer/T-Cell Lymphoma

(2011) Wan-Lin Teo et al.   JOURNAL OF CLINICAL ONCOLOGY

Epstein-Barr Virus BART9 miRNA Modulates LMP1 Levels and Affects Growth Rate of Nasal NK T Cell Lymphomas

(2011) Rajesh Ramakrishnan et al.   PLoS One

Distribution of lymphoid neoplasms in the Republic of Korea: Analysis of 5318 cases according to the World Health Organization classification

(2010) Sun Och Yoon et al.   AMERICAN JOURNAL OF HEMATOLOGY

A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy

(2010) C. P. Fox et al.   BLOOD

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

(2010) A. Jaccard et al.   BLOOD

Suppression of EBNA1 expression inhibits growth of EBV-positive NK/T cell lymphoma cells

(2010) Mo X-Lan et al.   CANCER BIOLOGY & THERAPY

Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro

(2010) J Iqbal et al.   LEUKEMIA

miRBase: integrating microRNA annotation and deep-sequencing data

(2010) A. Kozomara et al.   NUCLEIC ACIDS RESEARCH

Roles of small RNAs in tumor formation

(2010) Gianpiero Di Leva et al.   TRENDS IN MOLECULAR MEDICINE

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type

(2009) Y. Huang et al.   BLOOD

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

(2009) J. Iqbal et al.   BLOOD

Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type

(2009) Raymond Liang   BRITISH JOURNAL OF HAEMATOLOGY

Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3

(2009) Dai Iwakiri et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Identification of Epstein‐Barr Virus (EBV)–Infected Lymphocyte Subtypes by Flow Cytometric In Situ Hybridization in EBV‐Associated Lymphoproliferative Diseases

(2009) Hiroshi Kimura et al.   JOURNAL OF INFECTIOUS DISEASES

Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies

(2009) J Iqbal et al.   LEUKEMIA

STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma

(2009) P Coppo et al.   LEUKEMIA

The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species

(2009) B. Gruhne et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

(2008) W.-y. Au et al.   BLOOD

A Clinical Study of 115 Patients with Extranodal Natural Killer/T-cell Lymphoma, Nasal Type

(2008) X. Wu et al.   CLINICAL ONCOLOGY